Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Sponsor: Autolus Limited
Summary
Long-term follow-up of patients exposed to an AUTO CAR T cell therapy for up to 15 years following their first AUTO CAR T cell therapy infusion.
Official title: Long-term Follow-up of Patients Previously Treated With Autologous T Cells Genetically Modified With Viral Vectors
Key Details
Gender
All
Age Range
1 Year - Any
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2018-08-02
Completion Date
2043-12
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
AUTO CAR T cell therapy
No study drug is administered in this study. Patients previously treated with AUTO CAR T cell therapy will be monitored for safety following the first infusion.
Locations (8)
University of Miami
Miami, Florida, United States
Washington University in St. Louis
St Louis, Missouri, United States
St David's South Austin Medical Center
Austin, Texas, United States
Queen Elizabeth University Hospital
Glasgow, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Manchester Royal Infirmary Hospital
Manchester, United Kingdom
Royal Manchester Children's Hospital
Manchester, United Kingdom
Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom